StockNews.com Lowers BIOLASE (NASDAQ:BIOL) to Sell : compare

StockNews.com lowered shares of BIOLASE (NASDAQ:BIOL – Free Report) from a hold rating to a sell rating in a research report report published on Thursday. BIOLASE Price Performance Shares of NASDAQ:BIOL traded up $0.04 during midday trading on Thursday, reaching $0.89. 45,625 shares of the company were exchanged, compared to its average volume of 74,141. […]

Related Keywords

United States , , Renaissance Technologies , Biolase Inc , Walleye Capital , Nasdaq , Acadian Asset Management , Citadel Advisors , Free Report , Get Free Report , Asset Management , State Street Corp , Street Corp , Biolase , Nasdaq Biol , Fbiol , Medical , Downgrade , Stocknews Com ,